Investors

Financial Information

한미약품의 경영지표를 확인하실 수 있습니다.

Summarized Income Statement

(1 million won , K-IFRS)
Quarterly and yearly information
Category 2016 2015 2014 2013 2012
Sales revenue 882,724 1,317,535 761,280 730,134 674,005
Cost of sales 421,869 398,251 338,777 313,680 279,326
Gross profit 460,855 919,284 422,503 416,454 394,679
Selling general administrative expenses 291,189 539,496 252,883 259,594 266,549
Ordinary development costs 142,894 167,987 135,168 94,965 79,987
Operating income(Loss) 26,771 211,800 34,452 61,895 48,143
Finance income 8,472 1,015 3,943 4,239 3,469
Finance cost 10,458 12,346 12,196 14,891 17,594
Other income 47,170 33,404 16,452 11,094 7,354
Other expenses 69,958 24,288 6,190 7,508 9,168
Profit (loss) before tax 7,997 209,585 36,461 54,829 32,205
Income tax expense (22,302) 47,524 6,834 4,295 3,450
Profit (loss) 30,299 162,060 43,295 50,534 28,755
Other comprehensive income (13,043) (6,090) (10,789) 3,385 2,540
Total comprehensive income 17,256 155,970 32,506 53,920 31,295